Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma

Published:2015-02 Issue:2 Volume:33 Page:69.e11-69.e18
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Lebdai Souhil,Verhoest Gregory,Parikh Hemang,Jacquet Solène Florence,Bensalah Karim,Chautard Denis,Rioux Leclercq Nathalie,Azzouzi Abdel Rahmène,Bigot Pierre

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference26 articles.

1. Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions;Rini;Clin Cancer Res,2007

2. Challenges of cancer biomarker profiling;Bensalah;Eur Urol,2007

3. EAU guidelines on renal cell carcinoma: the 2010 update;Ljungberg;Eur Urol,2010

4. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology;Zigeuner;Eur Urol,2010

5. Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer;Comuzzi;Cellscience,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion;Cancer Letters;2024-10

2. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway;Journal of Ovarian Research;2024-02-23

3. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway;2023-09-26

4. Gene LY96 is an M2 macrophage‐related biomarker and is associated with immunosuppression in renal cell carcinoma;MedComm – Oncology;2023-09

5. Transcriptome profiling in ovarian cancer cells treated with platelets reveals that TGFBI as a novel prognostic indicator;2022-11-11